Skip to main content
. 2015 May 12;2:1–14. doi: 10.1016/j.plabm.2015.04.001

Table 1b.

Characteristics for manual and automated commercial 25OHD assays according to insertrs.

Platform vendor Extraction and purification procedures Assay principle Equivalence 25OHD2/25OHD3, Cross-reactivity (C3-epi/24,25(OH)2D Traceability, recovery (%) LOQ/(LOD) (nmol/L) Precision, intra-assay, inter-assay, CV (%)
DiaSorin S/P acetonitrile RIA, 125I-CC, derivative goat polyclonal Ab Equivalence: Yes, cross-reactivity: Yes NR/100% Calibrators traceable to a pure preparation of the 25OHD Ag calculated by spectrophotometry 6.25a/(4.0) 11.7% at 21.5 nmol/L, 9.4% at 21.5 nmol/L
Immuno Diagnostics Ltd. S/P 50 μl, NaOH, acetonitrile RIA, 125I-25OHD Equivalence: 75%/100%, cross-reactivity: NR/≥100% Calibrators standardised by UV quantitation, 89–102 at 20 nmol/L NR/(3.0) 5.3% at 26 nmol/L, 8.2% at 20 nmol/L
Immuno Diagnostic Systems Ltd. S/P 25 μl, 2-step procedure w/o extraction ELISA, immobilized anti-25OHD, sheep polyclonal Ab, 25OHD-labeled with biotin HRP/TMB Equivalence: 75%/≥100%, cross-reactivity NR/≥100% Calibrators standardised by UV quantitation, 97–105 NR/(5.0) 5.3% at 39 nmol/L, 4.6% at 40 nmol/L
Immuno Diagnostic Systems Ltd. S 10 μl, 2-step procedure, Denaturation DBP+NaOH CLIA, acridinium-labeled anti-25OHD, sheep polyclonal Ab Equivalence: Yes, cross-reactivity: 1%/NR Calibrators standardised to ID-LC-/MS/MS) 25OHD RMP; traceable to the NIST SRM 2972, recovery not reported 17.5/(6.0) 6.2% at 30 nmol/L, 11.6% at 30 nmol/L
DiaSorin, Liaison, Total DiaSorin CLIA, HRP – isoluminol derivative Equivalence: Yes, cross-reactivity: 1.3%/NR Calibrators traceable to UV spectrophotometric analysis 10.0/(NR) 3.8% at 20 nmol/L, 12.2% at nmol/L
Advia, Centaur, Siemens S/P 20 μl, buffered releasing agent CLIA, acridinium-labeled mouse mAb, fluorescein vitamin D analog, anti-fluorescein mAb, PMP 1-anilinonaphthalene-8-sulfonic Equivalence: Yes 104%/100%, cross-reactivity: 1.1%/NR Calibrators standardised to ID-LC-/MS/MS, 25OHD RMP; traceable to the NIST SRM 2972, recovery not reported 10.5(8.0) 4.7% at 34 nmol/L, 11.9% at 34 nmol/L
Architect 1, Abbott S/P 60 μl, 2 step procedure, EtOH/triethanolamine/ANSA CLIA, Sheep polyclonal Ab-anti-25OHD, acridinium-labeled biotinylated anti-biotin IgG complex Equivalence: 82%/100%, cross-reactivity: 2.7%/112% NR, no mention of traceability, recovery not reported 20 (7.8) 3.1% at 58 nmol/L, 4.0% at 58 nmol/L
Roche Elecsys, Roche Diagnostics S/P 15 μl, 2 step procedure, Dithiothreitol pH 5.5, then NaOH ECL, CBPA, Ruthenium Equivalence: 92%/100%, cross-reactivity: 91%/149% Standardized against in house LC-MS/MS standardized to the NIST standard, recovery not reported 10 (7.5) 7.8% at 17 nmol/L
Vitros 5600, Vitros S 60 μl, 1 step procedure, acid pH CLIA, Sheep mcAB-anti-25OHD, Horseradish peroxidase – Luminol Equivalence: Yes, cross-reactivity: Yes 37.4%/34.3% In house reference calibrators, Correlation to LC/MS/MS, recovery not reported 32 (21.6) 7.4% at 56nmol/L, 14.0% at 56 nmol/L
Beckman Dxi, Beckman–Coulter S/P 30 μl, 1 step procedure, Tris buffered saline CLIA, Sheep mcAB-anti-25OHD 25OHD, analog AP-conjugate, Lumi-Phos* 530 Equivalence: Yes, cross-reactivity: 65%/0% Calibrators standardised to ID-LC-/MS/MS, 25OHD RMP; traceable to the NIST SRM 2972, recovery not reported 11 (3.7) 4.6% at 39 nmol/L, 8.1% at 39 nmol/L

Unless otherwise specified, the characteristics of the commercial assays are derived from the information given in the respective inserts. Recovery refers to the % of the exogenously added 25OHD3 (nmol/L) before extraction recovered at completion of the assay. RIA: radio immnuno assay; EIA: enzyme-linked immuno assay; CLIA: chemi luminescent immuno assay, CBPA: competitive binding-protein assay; ELISA: enzyme-linked immuno sorbent assay; CLIA: chemi luminesent immuno assay; ECL: electro chemiluminescence S: serum; P: plasma; LOQ: lower limit of quantification defined as a measure with a CV<20%; LOD: lower limit of detection defined as the lowest concentration that can be defined with a confidence of 95%; NR: not reported; CV: coefficient of variation at the lowest concentration tested. EtOH: Ethanol; 3H-25OHD2: [23,24(n)-3H]-25-hydroxyvitamin D3 or [26(27)-methyl-3H]-25-hydroxyvitamin D3; 125I-CC: vitamin D-23,24,25,26,27-pentanor-C(22)-carboxylic-amide-3-aminopropyl; ANSA: 8-anilino-1-naphthalene sulfonic acid; IgG: immunoglobulin G; mcAB: monoclonal antibody; BSA: bovine serum albumin; AP: alkaline phosphatase; Lumi-Phos* 530: trademark of Lumigen Inc. (Southfield, MI); ID-LC-/MS/MS: isotope dilution-liquid chromatography/tandem mass spectrometry; RMP: reference method procedure; NIST: National Institute of Standards and Technology; SRM: standard reference material

a

Personal communication (E Cavalier).